Startup Dossier
Enodia Therapeutics
Develops small-molecule drugs that trigger the degradation of disease-causing proteins as they are being synthesized, using a platform combining proteomics and machine learning.
active
Typestartup
SectorBioTech
LocationParis
About
Develops small-molecule drugs that trigger the degradation of disease-causing proteins as they are being synthesized, using a platform combining proteomics and machine learning.
Structural DNA
Legal Name
Enodia Therapeutics
SIREN
941266710
Founders & Team
Funding Lineage
Seed
Elaia (Lead)
€20.7M
Jan 2026